Our top stories this week: testosterone levels and prostate cancer risk, new cervical screening research and detecting oesophageal cancer earlier.
New research shows women who have had the HPV vaccine may only need 3 cervical screens in their entire life, rather than the 12 that are standard in the UK.
Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.
We’d like to introduce the latest bunch of scientists that we’ve given funding to head up their own research teams for the first time.
A world-first data report could help us understand whether cancer patients are getting the most appropriate treatments for them.
Radiotherapy doesn’t have to be given from outside the body. Radioactive implants and drinks stay close to tumours to minimise side effects.
A patient was diagnosed and treated for a brain tumour 8 days after seeing her optician with symptoms. The approach could speed up diagnosis.
The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries.
In this week’s news a drug was approved for some lung cancer patients in England, and vaping could be a big piece of the quitting smoking puzzle.